Study unravels mystery of cancer-fueling enzyme—could lead to new therapies
Peer-Reviewed Publication
Updates every hour. Last Updated: 10-Sep-2025 09:11 ET (10-Sep-2025 13:11 GMT/UTC)
New research offers unprecedented insight into how an enigmatic enzyme, known as CDK7, drives the cell cycle and cell proliferation.
A patient’s race and location may influence diagnostic testing for prostate tumors.
For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer’s disease and other chronic diseases. But these cells are also like needles in a haystack, difficult to identify by traditional scientific measures.
City of Hope opens phase 1 clinical trial aiming to transform rectal cancer into a disease treatable with radiation therapy to avoid potential long-term side effects of surgery. Physician scientists will evaluate an alternative use of an investigational enzyme inhibitor, papaverine, which is hypothesized to prime regions of tumors to be more susceptible to radiation therapy
A Japanese research team has discovered a novel global cooperative phenomena of cell interactions in cervical cancer cells. Their findings suggest that the cells are metabolically connected in a functional network. The framework they used in their studies could prove useful for investigating the hidden state of a group of cells.